Abbott Becomes Seattle Genetics’ Latest Antibody-Drug Conjugate Collaborator
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 4 (Table of Contents)
Published: 7 Apr-2011
DOI: 10.3833/pdr.v2011.i4.1454 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Seattle Genetics has added Abbott to its list of collaborators for its antibody-drug conjugate (ADC) technology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS